Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-262543
Filing Date
2025-11-03
Accepted
2025-11-03 16:06:32
Documents
22
Period of Report
2025-12-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A vivs-20251103.htm   iXBRL DEF 14A 905634
2 GRAPHIC img69967137_0.jpg GRAPHIC 23008
3 GRAPHIC img69967137_1.jpg GRAPHIC 5614
4 GRAPHIC img69967137_2.jpg GRAPHIC 5614
5 GRAPHIC img69967137_3.jpg GRAPHIC 23008
6 GRAPHIC img69967137_4.jpg GRAPHIC 390696
7 GRAPHIC img69967137_5.jpg GRAPHIC 369981
8 GRAPHIC img69967137_6.jpg GRAPHIC 5614
9 GRAPHIC img69967137_7.jpg GRAPHIC 1822751
10 GRAPHIC img69967137_8.jpg GRAPHIC 861436
  Complete submission text file 0001193125-25-262543.txt   10335878

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vivs-20251103.xsd EX-101.SCH 17310
24 EXTRACTED XBRL INSTANCE DOCUMENT vivs-20251103_htm.xml XML 341827
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-35996 | Film No.: 251444093
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)